STVN vs. NYXH, ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, ALVO, AONCW, and AONC
Should you be buying Stevanato Group stock or one of its competitors? The main competitors of Stevanato Group include Nyxoah (NYXH), 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), Alvotech (ALVO), American Oncology Network (AONCW), and American Oncology Network (AONC). These companies are all part of the "medical" sector.
Nyxoah (NASDAQ:NYXH) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment, institutional ownership and community ranking.
In the previous week, Stevanato Group had 6 more articles in the media than Nyxoah. MarketBeat recorded 6 mentions for Stevanato Group and 0 mentions for Nyxoah. Nyxoah's average media sentiment score of 0.20 beat Stevanato Group's score of 0.00 indicating that Stevanato Group is being referred to more favorably in the news media.
Nyxoah presently has a consensus price target of $20.60, indicating a potential upside of 82.46%. Given Stevanato Group's stronger consensus rating and higher probable upside, analysts clearly believe Nyxoah is more favorable than Stevanato Group.
Nyxoah has a beta of 1.5, suggesting that its stock price is 50% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500.
Stevanato Group has a net margin of 13.43% compared to Stevanato Group's net margin of -993.28%. Nyxoah's return on equity of 14.31% beat Stevanato Group's return on equity.
Stevanato Group has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.
Stevanato Group received 1 more outperform votes than Nyxoah when rated by MarketBeat users. Likewise, 63.41% of users gave Stevanato Group an outperform vote while only 62.50% of users gave Nyxoah an outperform vote.
Summary
Stevanato Group beats Nyxoah on 11 of the 14 factors compared between the two stocks.
Get Stevanato Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for STVN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding STVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Stevanato Group Competitors List
Related Companies and Tools
